dihexa c-met cancer risk Targeting Alterations in Cancer: A Review of Genetic Drivers and Therapeutic Implications Global and regional cancer burden
Global and regional cancer burden attributable to modifiable risk factors to inform prevention IARC Dihexa: The Truth About the Most Potent Synaptogenic Peptide Hepatocyte Growth Factor c Met Signaling in Head and Neck Cancer and Implications for Treatment dihexa hgf c met cancer risk HGF c MET pathway in cancer: from molecular characterization to clinical evidence Targeted Inhibition of Hepatocyte Growth Dihexa targets neurotrophic factors like BDNF and NGF, which drive brain repair. By activating the c MET receptor, it helps cells take in nutrients and rebuildespecially in cases where recovery is slow or Targeting c MET in gastrointestinal tumours: rationale, opportunities and challenges Nature Reviews Clinical Oncology
Pay in 4 interest-free payments of $5.61 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




